VI
RDY icon

Vestcor Inc’s Dr. Reddy's Laboratories RDY Stock Holding History

Vestcor Inc’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-36,114
Closed -$507K – 1278
2025
Q4 		$507K Sell
36,114
-23,000
-39% -$323K 0.01% 699
2025
Q3 		$826K Sell
59,114
-28,782
-33% -$414K 0.02% 557
2025
Q2 		$1.32M Sell
87,896
-293,774
-77% -$4.2M 0.04% 412
2025
Q1 		$5.03M Hold
381,670
– – 0.17% 138
2024
Q4 		$6.03M Sell
381,670
-41,715
-10% -$627K 0.2% 115
2024
Q3 		$6.73M Hold
423,385
– – 0.21% 111
2024
Q2 		$6.45M Hold
423,385
– – 0.22% 113
2024
Q1 		$6.21M Hold
423,385
– – 0.21% 114
2023
Q4 		$5.89M Sell
423,385
-36,465
-8% -$488K 0.2% 109
2023
Q3 		$6.15M Sell
459,850
-87,645
-16% -$1.19M 0.23% 105
2023
Q2 		$6.91M Hold
547,495
– – 0.25% 95
2023
Q1 		$6.23M Hold
547,495
– – 0.23% 108
2022
Q4 		$5.67M Sell
547,495
-68,205
-11% -$736K 0.21% 113
2022
Q3 		$6.45M Hold
615,700
– – 0.24% 96
2022
Q2 		$6.82M Sell
615,700
-76,075
-11% -$827K 0.25% 90
2022
Q1 		$7.71M Buy
691,775
+6,240
+0.9% +$70.7K 0.26% 95
2021
Q4 		$8.97M Buy
685,535
+42,260
+7% +$533K 0.32% 85
2021
Q3 		$8.38M Buy
643,275
+70,465
+12% +$939K 0.3% 90
2021
Q2 		$8.42M Buy
572,810
+79,790
+16% +$1.12M 0.28% 96
2021
Q1 		$6.05M Sell
493,020
-30,000
-6% -$385K 0.23% 130
2020
Q4 		$7.46M Hold
523,020
– – 0.31% 98
2020
Q3 		$7.28M Buy
523,020
+19,195
+4% +$229K 0.34% 85
2020
Q2 		$5.34M Buy
503,825
+164,500
+48% +$1.67M 0.28% 112
2020
Q1 		$2.74M Hold
339,325
– – 0.15% 164
2019
Q4 		$2.75M Buy
+339,325
New +$2.68M 0.13% 211

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Vestcor Inc's RDY Position: Q1 2026 in Review

Vestcor Inc sold out of Dr. Reddy's Laboratories (RDY) in Q1 2026, closing a stake of 36,114 shares — an estimated $507K sold.

Vestcor Inc first reported a position in RDY in Q4 2019 and held it in 25 quarters. The position peaked at $8.97M in Q4 2021. 249 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • Vestcor Inc reported no remaining Dr. Reddy's Laboratories position as of Q1 2026 after selling out during the quarter.
  • Vestcor Inc sold 36,114 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $507K.
  • Vestcor Inc first reported a position in Dr. Reddy's Laboratories in Q4 2019 and held it in 25 quarters.
  • Vestcor Inc's Dr. Reddy's Laboratories position peaked at $8.97M in Q4 2021.
  • 249 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.